Dr. Jaffee is an internationally recognized expert in cancer immunology and pancreatic cancers with specific expertise in the pre-clinical and early clinical development of immunotherapies for pancreatic cancers. She focuses on understanding the inflammatory responses that are associated with cancer development and progression in pre-clinical and clinical studies. She develops novel vaccine approaches for the treatment of pancreatic and new methodologies for identifying vaccine induced T cell and antibody targets. She has mentored 26 post-doctoral fellows and 25 graduate students, and has over 160 peer review publications. Dr. Jaffee holds 6 vaccine patents, and has been a Principal Investigator and IND sponsor on many immunotherapy Clinical Studies. She is an international expert in cancer immunology with specific expertise in the pre-clinical and early clinical development of immunotherapies for breast and pancreatic cancers. Dr. Jaffee has more than 160 peer review publications. She runs an NIH funded laboratory dedicated to developing novel immunotherapies and her scientific leadership role includes junior faculty, graduate student, and postdoctoral mentorship. Altogether, she has mentored 26 post-doctoral fellows and 25 graduate students many of whom are currently leaders in their scientific fields. She has served on a number of committees at the National Cancer Institute and is currently chair of the National Cancer Advisory Board as well as co-chair of the Blue Ribbon Panel that provided scientific advice for Vice President Biden’s Moonshot Initiative. She has served on the Board of Directors for AACR, chaired the AACR CIMM Steering Committee, was Co-Organizer for the AACR Special Conference on Cancer Immunology in 2010 and 2012, and a Keystone meeting dedicated to Immune Based Therapies in 2015. Dr. Jaffee is Present-Elect of AACR for the 2017-2018 Term.